The nanopore can electrophoretically trap single DNA/RNA molecules for genetic/epigenetic detections. However, low selectivity for complex samples (extracts from plasma) remains the challenge to clinical applications. We report an novel biophysical mechanism--Carrier-guided-Nanopore-Dielectrophoresis(CND)--for selective nucleic acids detection. We invented a polycationic micro-carrier. Upon hybridization with the target, the target•carrier forms a moment-tunable dipole, which can be attracted into the nanopore by dielectrophoresis from a huge electric field gradient (107V/m-per-nm) outside the nanopore entrance. In contrast, any non-target species without carrier hybridization carries negative charge and would electrophoretically migrate away from the nanopore. Consequently only the target•carrier nanopore signatures can be identified; any interference signal from non-target nucleic acids is completely eliminated. Unlike electrophoresis that lacks selectivity, the nanopore dielectrophoresis can selectively drive target nucleic acids of any size by using a universal micro-carrier. This represents the first and substantial step in translating the nanopore-sensor into a clinically-usable tool for molecular diagnostics. We demonstrate how to utilize this mechanism to accurately quantify cancer-derived microRNA biomarkers in patient plasma.Nat.Nanotech._DOI:10.1038/NNANO.2011.147.ACS_Nano_DOI:10.1021/nn305789zView Large Image | View Hi-Res Image | Download PowerPoint Slide